470
Participants
Start Date
February 28, 2003
Primary Completion Date
April 30, 2006
Study Completion Date
August 31, 2013
A (Thalidomide + Dexamethasone)
Thalidomide 50mg/day + Dexamethasone 40mg
B (Placebo + Dexamethasone)
Placebo + Dexamethasone 40mg
Hope Directorate Dep't. Haematology St. James's Hospital, Dublin
Universita di Bari Dipartimento di Scienze Umana Sezione de Medicina Interna e Oncologia Medica Policlinico, Bari
University Hospital Ghent Dep't of Haematology, Ghent
Institut Jules Bordet Dep't of Clinical Haematology, Brussels
Dept. Of Haematology Academisch Ziekenhuis VUB, Brussels
National Center of Haematology and Transfusiology, Sofia
Peter MacCallum Cancer Institute, Melbourne
The Alfred Hospital, Melbourne
Bone Marrow Transplant Service Dept of Clinical Haematology and Medical Oncology, Parkville
Frankston Hospital, Frankston
Royal Brisbane Hospital, Herston
Haematology Princess Alexandra Hospital, Woolloongabba
Universitatsspital Zurich, Zurich
Petz Aladar County Hospital, Győr
Zhitomir Regional Clinical Hospital Hematology Centre, Zhytomyr
SUNY Upstate Medical University, Syracuse
University of Pittsburgh, Pittsburgh
Azienda Ospedaliera San Martino, Genova
Cherkassy Regional Oncology Center, Cherkassy
Ospedale Niguarda Ca Granda, Milan
Policlinico San Matteo, Pavia
Hospital Universitario de la Princessa, Madrid
Hospital Doce de Octubre, Madrid
South Carolina Oncology Group, West Columbia
Clinica Universitaria de Navarra, Pamplona
Rambam Medical Center Dep't. Of Hematology, Haifa
Mayo Clinic, Jacksonville
Clinica Ematologica Policlinico Universitario, Udine
Jackson Memorial Hospital and Clinics, Miami
University of Miami Miller School/Jackson Memorial Hospital, Miami
University of Miami, Miami
Oncology Hematology Group of South Florida, Miami
Clinical Research Consultants, Inc., Hoover
Hospital Universitario de Salamanca, Salamanca
East Tennessee Oncology/Hematology Associates, Knoxville
The Family Centre, PLLC, Collierville
Hospital Universitario Marques de Valdecilla, Santander
"Istituto di Ematologia e Oncologia Medica L. e. A. Seragnoli", Bologna
Cleveland Clinic- Taussig Cancer Center, Cleveland
Dnepropetrovsk City Clinical Hospital #4 Regional Hematology Centre, Dnipro
University of Iowa Hospital of Clinic, Iowa City
Director of Hematology Division BMT and CBB The Chaim Sheba Medical Center, Tel Litwinsky
Medical College of Wisconsin, Milwaukee
Mayo Clinic Cancer Center, Rochester
Kharkov Regional Clinical Oncology Center Dep't of Oncology and Pediatric Oncology, Kharkiv
Southern Illinois Hematology /Oncology, Centralia
Tel Aviv Sourasky Medical Center Hematology Institute, Tel Aviv
Odessa Regional Clinical Hospital Hematology Dep't, Odesa
Zaporozhje Regional Clinical Hospital Hematology Dpt, Zaporizhzhya
Ocshner Clinic Foundation, New Orleans
Ivano-Frankovsk Regional Clinical Hospital - Hospital Therapy Department, Ivano-Frankivsk
Institute of Blood Pathology and Transfusion Medicine of the UAMS, Lviv
Arizona Clinical Research Center, Tucson
James Berenson, West Hollywood
UCLA School of Medicine, Los Angeles
Hadassah University Hospital Hematology Dep't, ‘En Kerem
Burdenko Central Military Clinical Hospital Hematology Center, Moscow
Blokhin Cancer Research Center Dpt of Myeloproliferative Disorders Chemotherapy, Shosse
Russian Academy of Medical Sciences Scientific Center of Hematology, Moscow
Research Institute of Hematology and Blood Transfusion,Clinical Department of Hematology with Bone Marrow Transplantation Unit, Saint Petersburg
St. Petersburg Pavlov State Medical University Bone Marrow Transplantation Clinic, Saint Petersburg
Clinical Hospital #31 Dpt of Bone Marrow Transplantation and Chemotherapy of Patients with Myeloproliferative Disorders, Saint Petersburg
Republican Clinical Hospital #1 Hematology Dpt., Izhevsk
Samara Regional Clinical Hospital Dep't. of Hematology and Bone Marrow Transplantation, Samara
Chelyabinsk Regional Clinical Hospital Hematology Dpt, Chelyabinsk
Nizhny Novgorod Clinical Hospital, Veliky Novgorod
Ekaterinburg 1st Regional Clinical Hospital Regional Hematology Centre, Yekaterinburg
Novosibirsk State Regional Clinical Hospital Hematology Centre, Novosibirsk
Melbourne Internal Medicine Associates Oncology, Melbourne
Medical College of Georgia, Augusta
Rush Cancer Institute Section of Hematology, Chicago
University of Michigan Comprehensive Cancer Center, Ann Arbor
Hackensack University Hospital, Hackensack
Wake Forest University School of Medicine, Winston-Salem
UMHAT Alexandrovska, Alexandrovska
Military Medical Academy, Sofia
Universitaetsklinikum Dusseldorf Klinik fuer Haematologie, Düsseldorf
St. Laszlo Hoszpital, Budapest
MidWestern Regional Hospital Haematology Dpt., Dooradoyle
Dalhousie University, Halifax
Princess Margaret Hospital, Toronto
University Health Network Princess Margaret Hospital, Toronto
Centre Hopitalier Universitaire de Sherbrooke Hospital Fleurimont, Fleurimont
McGill University, Montreal
Saskatoon Cancer Centre University of Saskatoon, Saskatoon
Università La Sapienza Dipartimento di Biotecnologie Cellulari ed Ematologia, Roma
Medical Academy of Bialystok, Bialystok
Institute of Internal Diseases University of Medicine, Gdansk
Jagiellonian University Collegium Medicum Department of Hematology, Krakow
Medical University of Lodz, Lodz
Private Medical Practice Centre of Clinical Laboratory of Densitometry At 'Officers of Professors', Lublin
Medical University of Warsaw Dep't of Hematology, Oncology and Internal Diseases, Warsaw
Hospital Clinic, Barcelona
Kiev Institute of Oncology of the UAMS Systemic Malignancies Department, Kiev
Kiev Bone Marrow Transplantation Center Bone Marrow Transplantation Department, Kiev
Institute of Hematology and Transfusiology of the UAMS Department of Blood Diseases with Clinical Biochemistry Group, Kiev
Belfast City Hospital Haematology Dpt., Belfast
Guys Hospital, London
Guys Hospital, London
Lead Sponsor
Celgene Corporation
INDUSTRY